These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

771 related items for PubMed ID: 30280305

  • 1. Treatment of Hereditary Angioedema Attacks with Icatibant and Recombinant C1 Inhibitor During Pregnancy.
    Hakl R, Kuklínek P, Krčmová I, Králíčková P, Freiberger T, Janků P, Vlková M, Litzman J.
    J Clin Immunol; 2018 Oct; 38(7):810-815. PubMed ID: 30280305
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Hereditary angioedema with normal C1 inhibitor in a French cohort: Clinical characteristics and response to treatment with icatibant.
    Bouillet L, Boccon-Gibod I, Launay D, Gompel A, Kanny G, Fabien V, Fain O, IOS Study Group.
    Immun Inflamm Dis; 2017 Mar; 5(1):29-36. PubMed ID: 28250922
    [Abstract] [Full Text] [Related]

  • 4. First report of icatibant treatment in a pregnant patient with hereditary angioedema.
    Farkas H, Kőhalmi KV, Veszeli N, Tóth F, Varga L.
    J Obstet Gynaecol Res; 2016 Aug; 42(8):1026-8. PubMed ID: 27093898
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of recombinant human C1-inhibitor for the treatment of attacks of hereditary angioedema: European open-label extension study.
    Moldovan D, Reshef A, Fabiani J, Kivity S, Toubi E, Shlesinger M, Triggiani M, Montinaro V, Cillari E, Realdi G, Cancian M, Visscher S, Zanichelli A, Relan A, Cicardi M.
    Clin Exp Allergy; 2012 Jun; 42(6):929-35. PubMed ID: 22909164
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of recombinant human C1 esterase inhibitor across anatomic locations in acute hereditary angioedema attacks.
    Baker JW, Bernstein JA, Harper JR, Relan A, Riedl MA.
    Allergy Asthma Proc; 2018 Sep 28; 39(5):359-364. PubMed ID: 29954477
    [Abstract] [Full Text] [Related]

  • 7. Treatment of Hereditary Angioedema.
    Caballero T.
    J Investig Allergol Clin Immunol; 2021 Feb 28; 31(1):1-16. PubMed ID: 33602658
    [Abstract] [Full Text] [Related]

  • 8. Recombinant human C1 esterase inhibitor in the management of hereditary angioedema.
    Riedl M.
    Clin Drug Investig; 2015 Jul 28; 35(7):407-17. PubMed ID: 26091744
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Costs and effects of on-demand treatment of hereditary angioedema in Italy: a prospective cohort study of 167 patients.
    Federici C, Perego F, Borsoi L, Crosta V, Zanichelli A, Gidaro A, Tarricone R, Cicardi M.
    BMJ Open; 2018 Jul 30; 8(7):e022291. PubMed ID: 30061443
    [Abstract] [Full Text] [Related]

  • 11. [Administration of conestat alfa, human C1 esterase inhibitor and icatibant in the treatment of acute angioedema attacks in adults with hereditary angioedema due to C1 esterase inhibitor deficiency. Treatment comparison based on systematic review results].
    Kawalec P, Holko P, Paszulewicz A, Obtułowicz K.
    Pneumonol Alergol Pol; 2013 Jul 30; 81(2):95-104. PubMed ID: 23420425
    [Abstract] [Full Text] [Related]

  • 12. Therapeutic approaches in hereditary angioedema.
    Antoniu SA.
    Clin Rev Allergy Immunol; 2011 Aug 30; 41(1):114-22. PubMed ID: 21279474
    [Abstract] [Full Text] [Related]

  • 13. Bradykinin mediated gastrointestinal edema as a cause of abdominal attacks in patients with hereditary angioedema due to C1-inhibitor deficiency.
    Obtulowicz P, Piotrowicz-Wojcik K, Dyga W, Stobiecki M, Popiela T, Obtulowicz K.
    J Physiol Pharmacol; 2022 Apr 30; 73(2):. PubMed ID: 36193964
    [Abstract] [Full Text] [Related]

  • 14. Recombinant human C1 esterase inhibitor treatment for hereditary angioedema attacks in children.
    Reshef A, Grivcheva-Panovska V, Kessel A, Kivity S, Klimaszewska-Rembiasz M, Moldovan D, Farkas H, Gutova V, Fritz S, Relan A, Giannetti B, Magerl M.
    Pediatr Allergy Immunol; 2019 Aug 30; 30(5):562-568. PubMed ID: 30993784
    [Abstract] [Full Text] [Related]

  • 15. Recombinant human C1 esterase inhibitor for the treatment of hereditary angioedema due to C1 inhibitor deficiency (C1-INH-HAE).
    Sabharwal G, Craig T.
    Expert Rev Clin Immunol; 2015 Mar 30; 11(3):319-27. PubMed ID: 25669442
    [Abstract] [Full Text] [Related]

  • 16. Recombinant human C1 esterase inhibitor (Conestat alfa) for prophylaxis to prevent attacks in adult and adolescent patients with hereditary angioedema.
    Valerieva A, Caccia S, Cicardi M.
    Expert Rev Clin Immunol; 2018 Sep 30; 14(9):707-718. PubMed ID: 30021471
    [Abstract] [Full Text] [Related]

  • 17. Recombinant human C1 esterase inhibitor for acute hereditary angioedema attacks with upper airway involvement.
    Riedl MA, Li HH, Cicardi M, Harper JR, Relan A.
    Allergy Asthma Proc; 2017 Nov 13; 38(6):462-466. PubMed ID: 28903805
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Recombinant Human C1-Esterase Inhibitor to Treat Acute Hereditary Angioedema Attacks in Adolescents.
    Baker JW, Reshef A, Moldovan D, Harper JR, Relan A, Riedl MA.
    J Allergy Clin Immunol Pract; 2017 Nov 13; 5(4):1091-1097. PubMed ID: 28202404
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.